TMBR
Timber Pharmaceuticals, Inc.
TMBR
TMBR
Delisted
TMBR was delisted on the 28th of November, 2023.
23 hedge funds and large institutions have $7.5M invested in Timber Pharmaceuticals, Inc. in 2018 Q2 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 3 reducing their positions, and 5 closing their positions.
Holders
23
Holders Change
-2
Holders Change %
-8%
% of All Funds
0.53%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
7
Reduced
3
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Barclays
London,
United Kingdom
|
$181K |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$71K |
| 3 |
VF
3
Virtu Financial
New York
|
$128K |
| 4 |
4
Invesco
Atlanta,
Georgia
|
$11K |
| 5 |
5
Millennium Management
New York
|
$4K |
Top Sellers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$1.13M |
| 2 |
MA
2
MCF Advisors
Covington,
Kentucky
|
$0 |
| 3 |
3
Jane Street
New York
|
$0 |
| 4 |
TSS
4
Two Sigma Securities
New York
|
$0 |
| 5 |
5
UBS Group
Zurich,
Switzerland
|
$2K |
